Pancreatic cancer risk factors: Difference between revisions
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The most potent risk factors for Pancreatic cancer include smoking, alcoholism, increased BMI, diabetes mellitus, chronic pancreatitis and a family history of pancreatic cancer. Individuals with hereditary pancreatitis, familial pancreatic cancer, Peutz-Jeghers disease, familial atypical mole melanoma, cystic fibrosis of the pancreas and familial cancer syndromes such as lynch syndrome, familial adenomatous polyposis (FAP) and hereditary breast and ovarian cancer-BRCA1 and BRCA2 mutations are also at an increased risk of pancreatic cancer. | The most potent risk factors for Pancreatic cancer include [[smoking]], [[alcoholism]], increased [[Body mass index|BMI]], [[diabetes mellitus]], [[chronic pancreatitis]] and a family history of pancreatic cancer. Individuals with [[hereditary pancreatitis]], familial pancreatic cancer, Peutz-Jeghers disease, familial atypical mole melanoma, cystic fibrosis of the pancreas and familial cancer syndromes such as [[Hereditary nonpolyposis colorectal cancer|lynch syndrome]], [[familial adenomatous polyposis]] (FAP) and hereditary breast and ovarian cancer-[[BRCA1]] and [[BRCA2]] mutations are also at an increased risk of pancreatic cancer. | ||
==Risk Factors== | ==Risk Factors== | ||
Line 24: | Line 24: | ||
{| | {| | ||
! | ! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | '''Risk factors for Pancreatic Cancer''' | ||
|+ | |+ | ||
| | | colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Risk factors''' | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Smoking | *Smoking | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Alcohol | *Alcohol | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Increased BMI | *Increased BMI | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Diabetes mellitus | *Diabetes mellitus | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Chronic pancreatitis | *Chronic pancreatitis | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Family history of pancreatic cancer | *Family history of pancreatic cancer | ||
|- | |- | ||
|+ | |+ | ||
| | | colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | '''Familial Cancer Syndromes''' | ||
|+ | |+ | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*BRCA1, BRCA2 | *BRCA1, BRCA2 | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Familial adenomatous polyposis (FAP) | *Familial adenomatous polyposis (FAP) | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Peutz-Jeghers syndrome | *Peutz-Jeghers syndrome | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Familial atypical multiple mole melanoma syndrome (FAMMM) | *Familial atypical multiple mole melanoma syndrome (FAMMM) | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Lynch syndrome | *Lynch syndrome | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*von Hippel-Lindau syndrome | *von Hippel-Lindau syndrome | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Multiple endocrine neoplasia type 1 | *Multiple endocrine neoplasia type 1 | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Gardner syndrome | *Gardner syndrome | ||
|- | |- | ||
|+ | |+ | ||
| | | colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | '''Other medical conditions''' | ||
|+ | |+ | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Inflammatory bowel disease | *Inflammatory bowel disease | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Periodontal disease | *Periodontal disease | ||
|- | |- | ||
| style="background:#F5F5F5; + | | | style="background:#F5F5F5; + " | | ||
*Peptic ulcer disease | *Peptic ulcer disease | ||
|- | |- | ||
|} | |} | ||
<br/> | <br /> | ||
*'''Risk Factors and Inherited Syndromes associated with Pancreatic Cancer:'''<ref name="pmid25207767">{{cite journal| author=Ryan DP, Hong TS, Bardeesy N| title=Pancreatic adenocarcinoma. | journal=N Engl J Med | year= 2014 | volume= 371 | issue= 11 | pages= 1039-49 | pmid=25207767 | doi=10.1056/NEJMra1404198 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25207767 }} </ref> | *'''Risk Factors and Inherited Syndromes associated with Pancreatic Cancer:'''<ref name="pmid25207767">{{cite journal| author=Ryan DP, Hong TS, Bardeesy N| title=Pancreatic adenocarcinoma. | journal=N Engl J Med | year= 2014 | volume= 371 | issue= 11 | pages= 1039-49 | pmid=25207767 | doi=10.1056/NEJMra1404198 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25207767 }} </ref> | ||
Line 95: | Line 95: | ||
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + | '''Risk Factors and Inherited Syndromes associated with Pancreatic Cancer''' | ! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + | '''Risk Factors and Inherited Syndromes associated with Pancreatic Cancer''' | ||
|+ | |+ | ||
| | | colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" + | '''Risk Factor''' | ||
| | | colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" + | '''Approximate Risk''' | ||
|- | |- | ||
| style="background:#DCDCDC; + | Smoking | | style="background:#DCDCDC; + " | Smoking | ||
| style="background:#F5F5F5; + | 2-3 % | | style="background:#F5F5F5; + " | 2-3 % | ||
|- | |- | ||
| style="background:#DCDCDC; + | Long-standing Diabetes mellitus | | style="background:#DCDCDC; + " | Long-standing Diabetes mellitus | ||
| style="background:#F5F5F5; + | 2 % | | style="background:#F5F5F5; + " | 2 % | ||
|- | |- | ||
| style="background:#DCDCDC; + | Nonhereditery and Chronic Pancreatitis | | style="background:#DCDCDC; + " | Nonhereditery and Chronic Pancreatitis | ||
| style="background:#F5F5F5; + | 2-6 % | | style="background:#F5F5F5; + " | 2-6 % | ||
|- | |- | ||
| style="background:#DCDCDC; + | Obesity, Inactivity or both | | style="background:#DCDCDC; + " | Obesity, Inactivity or both | ||
| style="background:#F5F5F5; + | 2 % | | style="background:#F5F5F5; + " | 2 % | ||
|- | |- | ||
| style="background:#DCDCDC; + | Non O Blood Group | | style="background:#DCDCDC; + " | Non O Blood Group | ||
| style="background:#F5F5F5; + | 1-2 % | | style="background:#F5F5F5; + " | 1-2 % | ||
|+ | |+ | ||
| | | colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | '''Genetic Syndrome and Associated Gene or Genes''' | ||
|+ | |+ | ||
|- | |- | ||
| style="background:#DCDCDC; + | Hereditary pancreatitis (PRSS1, SPINK1) | | style="background:#DCDCDC; + " | Hereditary pancreatitis (PRSS1, SPINK1) | ||
| style="background:#F5F5F5; + | 50 % | | style="background:#F5F5F5; + " | 50 % | ||
|- | |- | ||
| style="background:#DCDCDC; + | Familial atypical multiple mole and melanoma syndrome (p16) | | style="background:#DCDCDC; + " | Familial atypical multiple mole and melanoma syndrome (p16) | ||
| style="background:#F5F5F5; + | 10-20 % | | style="background:#F5F5F5; + " | 10-20 % | ||
|- | |- | ||
| style="background:#DCDCDC; + | Hereditary breast and ovarian cancer syndromes (BRCA1, BRCA2, PALB2) | | style="background:#DCDCDC; + " | Hereditary breast and ovarian cancer syndromes (BRCA1, BRCA2, PALB2) | ||
| style="background:#F5F5F5; + | 1-2 % | | style="background:#F5F5F5; + " | 1-2 % | ||
|- | |- | ||
| style="background:#DCDCDC; + | Peutz-Jeghers syndrome (STK11 [LKB1]) | | style="background:#DCDCDC; + " | Peutz-Jeghers syndrome (STK11 [LKB1]) | ||
| style="background:#F5F5F5; + | 30-40 % | | style="background:#F5F5F5; + " | 30-40 % | ||
|- | |- | ||
| style="background:#DCDCDC; + | Hereditary nonpolyposis colon cancer (Lynch syndrome) (MLH1, MSH2, MSH6) | | style="background:#DCDCDC; + " | Hereditary nonpolyposis colon cancer (Lynch syndrome) (MLH1, MSH2, MSH6) | ||
| style="background:#F5F5F5; + | 4 % | | style="background:#F5F5F5; + " | 4 % | ||
|- | |- | ||
| style="background:#DCDCDC; + | Ataxia-telangiectasia (ATM) | | style="background:#DCDCDC; + " | Ataxia-telangiectasia (ATM) | ||
| style="background:#F5F5F5; + | Unknown | | style="background:#F5F5F5; + " | Unknown | ||
|- | |- | ||
| style="background:#DCDCDC; + | Li-Fraumeni syndrome (P53) | | style="background:#DCDCDC; + " | Li-Fraumeni syndrome (P53) | ||
| style="background:#F5F5F5; + | Unknown | | style="background:#F5F5F5; + " | Unknown | ||
|- | |- | ||
|} | |} |
Revision as of 16:33, 15 November 2017
Pancreatic cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pancreatic cancer risk factors On the Web |
American Roentgen Ray Society Images of Pancreatic cancer risk factors |
Risk calculators and risk factors for Pancreatic cancer risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
The most potent risk factors for Pancreatic cancer include smoking, alcoholism, increased BMI, diabetes mellitus, chronic pancreatitis and a family history of pancreatic cancer. Individuals with hereditary pancreatitis, familial pancreatic cancer, Peutz-Jeghers disease, familial atypical mole melanoma, cystic fibrosis of the pancreas and familial cancer syndromes such as lynch syndrome, familial adenomatous polyposis (FAP) and hereditary breast and ovarian cancer-BRCA1 and BRCA2 mutations are also at an increased risk of pancreatic cancer.
Risk Factors
- The most potent risk factors for Pancreatic cancer include smoking, alcoholism, increased BMI, diabetes mellitus, chronic pancreatitis and a family history of pancreatic cancer.
- Individuals with the following conditions are also at an increased risk of pancreatic cancer:[1]
- Hereditary pancreatitis
- Familial pancreatic cancer
- Peutz-Jeghers disease
- Familial atypical mole melanoma
- Cystic fibrosis of pancreas,
- Familial cancer syndromes such as:
- Lynch syndrome
- Familial adenomatous polyposis (FAP)
- Hereditary breast and ovarian cancer-BRCA1 and BRCA2 mutations
- Risk factors for Pancreatic cancer are illustrated in the following tables:
- Risk factors for Pancreatic Cancers:[2]
Risk factors for Pancreatic Cancer |
---|
Risk factors |
|
|
|
|
|
|
Familial Cancer Syndromes |
|
|
|
|
|
|
|
|
Other medical conditions |
|
|
|
- Risk Factors and Inherited Syndromes associated with Pancreatic Cancer:[3]
Risk Factors and Inherited Syndromes associated with Pancreatic Cancer | |||
---|---|---|---|
Risk Factor | Approximate Risk | ||
Smoking | 2-3 % | ||
Long-standing Diabetes mellitus | 2 % | ||
Nonhereditery and Chronic Pancreatitis | 2-6 % | ||
Obesity, Inactivity or both | 2 % | ||
Non O Blood Group | 1-2 % | ||
Genetic Syndrome and Associated Gene or Genes | |||
Hereditary pancreatitis (PRSS1, SPINK1) | 50 % | ||
Familial atypical multiple mole and melanoma syndrome (p16) | 10-20 % | ||
Hereditary breast and ovarian cancer syndromes (BRCA1, BRCA2, PALB2) | 1-2 % | ||
Peutz-Jeghers syndrome (STK11 [LKB1]) | 30-40 % | ||
Hereditary nonpolyposis colon cancer (Lynch syndrome) (MLH1, MSH2, MSH6) | 4 % | ||
Ataxia-telangiectasia (ATM) | Unknown | ||
Li-Fraumeni syndrome (P53) | Unknown |
References
- ↑ Goral V (2015). "Pancreatic Cancer: Pathogenesis and Diagnosis". Asian Pac J Cancer Prev. 16 (14): 5619–24. PMID 26320426.
- ↑ Bond-Smith G, Banga N, Hammond TM, Imber CJ (2012). "Pancreatic adenocarcinoma". BMJ. 344: e2476. doi:10.1136/bmj.e2476. PMID 22592847.
- ↑ Ryan DP, Hong TS, Bardeesy N (2014). "Pancreatic adenocarcinoma". N Engl J Med. 371 (11): 1039–49. doi:10.1056/NEJMra1404198. PMID 25207767.